4//SEC Filing
Barth Jay 4
Accession 0001209191-20-053165
CIK 0001178879other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:34 PM ET
Size
9.3 KB
Accession
0001209191-20-053165
Insider Transaction Report
Form 4
Barth Jay
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2020-09-30$2.29/sh+4,064$9,307→ 167,268 total - Sale
Common Stock
2020-09-30$14.51/sh−4,064$58,951→ 163,204 total - Exercise/Conversion
Stock Options (right to buy)
2020-09-30−4,064→ 14,666 totalExercise: $2.29Exp: 2024-03-03→ Common Stock (4,064 underlying)
Holdings
- 20(indirect: By Daughter)
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]All of the options were fully vested and exercisable as of the transaction date.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001601896
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:34 PM ET
- Size
- 9.3 KB